Veracyte (VCYT), MAVIDx Announce Agreement for MAVIDx to Develop Ultra-High Volume COVID-19 Testing on the nCounter System

Go back to Veracyte (VCYT), MAVIDx Announce Agreement for MAVIDx to Develop Ultra-High Volume COVID-19 Testing on the nCounter System

Veracyte and MAVIDx Announce Agreement for MAVIDx to Develop Ultra-High Volume COVID-19 Testing on the nCounter System

July 29, 2020 8:15 AM EDT

Novel approach may enable processing of over 40,000 patient samples per day using molecular barcodes for viral RNA

SOUTH SAN FRANCISCO, Calif., and MIAMI--(BUSINESS WIRE)-- Veracyte, Inc. (Nasdaq: VCYT) and... More